Aspire Pharma is a niche generic pharmaceutical company supplying over 400 products across ten therapy areas to patients in the UK and Europe.
Aspire Pharma is a niche generic pharmaceutical company founded in 2009. It identifies and serves underserved market segments, bringing niche generic medicines to patients in the United Kingdom and across Europe. The company was established from an entrepreneur's vision and describes its culture as rooted in agility and innovation.
Its portfolio comprises over 400 products spanning ten core therapy areas, among them urology, ophthalmology, dermatology and central nervous system treatments. Aspire Pharma is positioned as one of the largest and fastest-growing niche generic pharmaceutical companies in the UK and across Europe.
The company states that it values accountability, inclusivity and integrity, and encourages fresh thinking and innovative ways of working. Employees are empowered to contribute to its mission, with fair opportunities for all, an inclusive environment, support for professional growth, and an emphasis on collaboration and shared purpose.
Aspire Pharma is committed to sustainability, including support for a net-zero NHS by 2045. Its stated focus is on improving patient access and addressing rare and complex medical challenges.
